NEUROPATHOLOGICAL CHANGES IN SCRAPIE AND ALZHEIMERS-DISEASE ARE ASSOCIATED WITH INCREASED EXPRESSION OF APOLIPOPROTEIN-E AND CATHEPSIN-D IN ASTROCYTES

被引:287
作者
DIEDRICH, JF
MINNIGAN, H
CARP, RI
WHITAKER, JN
RACE, R
FREY, W
HAASE, AT
机构
[1] UNIV MINNESOTA,DEPT MICROBIOL,MINNEAPOLIS,MN 55455
[2] UNIV ALABAMA,DEPT NEUROL,BIRMINGHAM,AL 35294
[3] NEW YORK STATE INST BASIC RES,DEPT VIROL,STATEN ISL,NY 10314
[4] ROCKY MT LABS,PERSISTENT VIRAL DIS LAB,HAMILTON,MT 59840
[5] ST PAUL RAMSEY MED CTR,PSYCHIAT RES LABS,ST PAUL,MN 55101
关键词
D O I
10.1128/JVI.65.9.4759-4768.1991
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
With the rationale that the neuropathological similarities between scrapie and Alzheimer's disease reflect convergent pathological mechanisms involving altered gene expression, we set out to identify molecular events involved in both processes, using scrapie as a model to study the time course of these changes. We differentially screened a cDNA library constructed from scrapie-infected mice to identify mRNAs that increase or decrease during disease and discovered in this way two mRNAs that are increased in scrapie and Alzheimer's disease. These mRNAs were subsequently shown by sequence analysis to encode apolipoprotein E and cathepsin D (EC 3.4.23.5). Using in situ hybridization and immunocytochemistry to define the cellular and anatomic pathology of altered gene expression, we found that in both diseases the increase in gene expression occurred soon after the amyloid-forming abnormal isoform of the prion protein has been shown to accumulate in astrocytes. In Alzheimer's disease, the increased expression of cathepsin D also occurred in association with beta-amyloid. These studies reveal some of the molecular antecedents of neuropathological changes in scrapie and Alzheimer's disease and accord new prominence to the role of astrocytes in neurodegenerative conditions.
引用
收藏
页码:4759 / 4768
页数:10
相关论文
共 55 条
  • [31] LIBERSKI PP, 1989, ALZHEIMERS DISEASE R, P549
  • [32] Maniatis T., 1982, MOL CLONING
  • [33] AMYLOID PLAQUE CORE PROTEIN IN ALZHEIMER-DISEASE AND DOWN SYNDROME
    MASTERS, CL
    SIMMS, G
    WEINMAN, NA
    MULTHAUP, G
    MCDONALD, BL
    BEYREUTHER, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (12) : 4245 - 4249
  • [34] MONROY AF, 1988, BRL FOCUS, V10, P14
  • [35] A SPECIFIC 37,000-DALTON PROTEIN THAT ACCUMULATES IN REGENERATING BUT NOT IN NONREGENERATING MAMMALIAN NERVES
    MULLER, HW
    GEBICKEHARTER, PJ
    HANGEN, DH
    SHOOTER, EM
    [J]. SCIENCE, 1985, 228 (4698) : 499 - 501
  • [36] NORENBERG M, 1988, BIOCH PATHOLOGY ASTR
  • [37] HIGH-EFFICIENCY CLONING OF FULL-LENGTH CDNA
    OKAYAMA, H
    BERG, P
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1982, 2 (02) : 161 - 170
  • [38] GLIAL FIBRILLARY ACIDIC PROTEIN AND ALZHEIMERS-DISEASE
    PANTER, SS
    MCSWIGAN, JD
    SHEPPARD, JR
    EMORY, CR
    FREY, WH
    [J]. NEUROCHEMICAL RESEARCH, 1985, 10 (12) : 1567 - 1576
  • [39] PERRY G, 1989, ALZHEIMERS DISEASE R, P1021
  • [40] IMMUNOHISTOCHEMICAL LOCALIZATION OF PRION PROTEIN IN SPONGIFORM ENCEPHALOPATHIES AND NORMAL BRAIN-TISSUE
    PICCARDO, P
    SAFAR, J
    CERONI, M
    GAJDUSEK, DC
    GIBBS, CJ
    [J]. NEUROLOGY, 1990, 40 (03) : 518 - 522